Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EPHX1 | P07099 | 1/20 | 0.64 |
| ▸ | CPA1 | P15085 | 2/20 | 0.60 |
| ▸ | CPB1 | P15086 | 1/20 | 0.60 |
| ▸ | CPA3 | P15088 | 1/20 | 0.60 |
| ▸ | CPB2 | Q96IY4 | 1/20 | 0.60 |
| ▸ | ALPI | P09923 | 1/20 | 0.59 |
| ▸ | PKM | P14618 | 1/20 | 0.59 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.59 |
| ▸ | XIAP | P98170 | 1/20 | 0.59 |
| ▸ | SLC7A5 | Q01650 | 1/20 | 0.59 |
| ▸ | ANPEP | P15144 | 3/20 | 0.55 |
| ▸ | SLC15A1 | P46059 | 1/20 | 0.55 |
| ▸ | MMP2 | P08253 | 2/20 | 0.54 |
| ▸ | SLC1A3 | P43003 | 2/20 | 0.53 |
| ▸ | SLC1A2 | P43004 | 2/20 | 0.53 |
| ▸ | SLC1A1 | P43005 | 2/20 | 0.53 |
| ▸ | DPP4 | P27487 | 1/20 | 0.53 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.52 |
| ▸ | LTA4H | P09960 | 1/20 | 0.51 |
| ▸ | LAP3 | P28838 | 2/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL197907 | 1.00 | EPHX1 (0.64) | EPHX1CPA1CPB1CPA3CPB2 | |
| SCHEMBL287736 | 1.00 | EPHX1 (0.64) | EPHX1CPA1CPB1CPA3CPB2 | |
| Hydrochloric Acid SCHEMBL654577 | 0.98 | EPHX1 (0.61) | EPHX1CPA1CPB1CPA3CPB2 | |
| Hydrochloric Acid SCHEMBL654576 | 0.98 | EPHX1 (0.61) | EPHX1CPA1CPB1CPA3CPB2 | |
| Acetic Acid SCHEMBL6690172 | 0.94 | ALPI (0.58) | EPHX1CPA1CPB1CPA3CPB2 | |
| Trifluoroacetic Acid SCHEMBL1395876 | 0.91 | EPHX1 (0.53) | EPHX1CPA1CPB1CPA3CPB2 | |
| Trifluoroacetic Acid SCHEMBL6157790 | 0.91 | EPHX1 (0.53) | EPHX1CPA1CPB1CPA3CPB2 | |
| SCHEMBL29556848 | 0.89 | FFAR1 (0.55) | EPHX1CPA1CPB1CPA3CPB2 | |
| SCHEMBL2032416 | 0.89 | FFAR1 (0.55) | EPHX1CPA1CPB1CPA3CPB2 | |
| Hydrochloric Acid SCHEMBL1912599 | 0.87 | SRR (0.55) | EPHX1CPA1CPB1CPA3CPB2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 799 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117915957-A | Compositions and methods for modulating mRNA splicing | 恩特拉达治疗学股份有限公司 | 2024-04-19 | — | — | CN | claimed |
| EP-4337676-A1 | ANTIGEN-BINDING AND ANTIGEN DEGRADATION CONSTRUCTS | Entrada Therapeutics, Inc. (US) | 2024-03-20 | — | — | EP | claimed |
| CN-117561271-A | Cyclic cell penetrating peptides | 恩特拉达治疗公司 | 2024-02-13 | — | — | CN | claimed |
| WO-2023219933-A1 | COMPOSITIONS AND METHODS FOR DELIVERY OF NUCLEIC ACID THERAPEUTICS | ENTRADA THERAPEUTICS, INC. (US) | 2023-11-16 | — | — | WO | claimed |
| US-20230111252-A1 | THIOSEMICARBAZATES AND USES THEREOF | THE FEINSTEIN INSTITUTES FOR MEDICAL RESEARCH (US) | 2023-04-13 | — | — | US | claimed |
| US-11001609-B2 | Cell permeable cyclic peptide scaffolds | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2021-05-11 | — | — | US | claimed |
| CN-111655294-A | Ligand-drug-conjugates as substrates for selective cleavage by cathepsin B peptidase activity | 德比欧药物研究有限公司 | 2020-09-11 | — | — | CN | claimed |
| US-20200157149-A1 | Cell Permeable Cyclic Peptide Scaffolds | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA | 2020-05-21 | — | — | US | claimed |
| US-9982015-B2 | Cyclin based inhibitors of CDK2 and CDK4 | UNIVERSITY OF SOUTH CAROLINA (US) | 2018-05-29 | — | — | US | claimed |
| US-9896481-B2 | Modified mini-hepcidin peptides and methods of using thereof | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2018-02-20 | — | — | US | claimed |
| US-8580997-B2 | Process for preparing R-beta-amino phenylbutyric acid derivatives | JIANGSU HENGRUI MEDICINE CO. LTD. (CN) | 2013-11-12 | — | — | US | claimed |
| US-8466108-B2 | TFPI inhibitors and methods of use | BAXTER INTERNATIONAL INC. (US) | 2013-06-18 | — | — | US | claimed |
| WO-2012150495-A1 | SYNTHETIC PEPTIDES AND RANDOM COPOLYMERS FOR THE TREATMENT OF AUTOIMMUNE DISORDERS | NATIONAL INSTITUTE OF IMMUNOLOGY (IN) | 2012-11-08 | — | — | WO | claimed |
| EP-2379096-A2 | TFPI INHIBITORS AND METHODS OF USE | Baxter International Inc. (US) | 2011-10-26 | — | — | EP | claimed |
| US-20110130587-A1 | PROCESS FOR PREPARING R-BETA-AMINO PHENYLBUTYRIC ACID DERIVATIVES | JIANGSU HENGRUI MEDICINE CO., LTD. (CN) | 2011-06-02 | — | — | US | claimed |
| EP-2308829-A1 | A PROCESS FOR PREPARING R-BETA-AMINO PHENYLBUTYRIC ACID DERIVATIVES | Jiangsu Hengrui Medicine Co., Ltd. (CN) | 2011-04-13 | — | — | EP | claimed |
| WO-2010071894-A2 | TFPI INHIBITORS AND METHODS OF USE | BAXTER INTERNATIONAL INC. (US) | 2010-06-24 | — | — | WO | claimed |
| EP-1882740-B1 | N-acetyl-(R,S)-B-amino acid acylase gene | AJINOMOTO KK (JP) | 2010-04-14 | — | — | EP | claimed |
| US-20080241895-A1 | N-Acetyl-(R,S)-beta-Amino Acid Acylase Gene | AJINOMOTO CO., INC. (JP) | 2008-10-02 | — | — | US | claimed |
| EP-1882740-A1 | N-acetyl-(R,S)-B-amino acid acylase gene | Ajinomoto Co., Ltd. (JP) | 2008-01-30 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11001609-B2 | Cell permeable cyclic peptide scaffolds | VIP, IAPP, HM13 | EPHX1 4192/4885CPA1 354/4885CPB1 553/4885 |
| US-20230111252-A1 | THIOSEMICARBAZATES AND USES THEREOF | TST, ABAT, AADAC | EPHX1 3317/4885CPA1 1085/4885CPB1 109/4885 |
| US-20080241895-A1 | N-Acetyl-(R,S)-beta-Amino Acid Acylase Gene | ACSL4, FASN, BLVRB | EPHX1 3502/4885CPA1 2925/4885CPB1 631/4885 |
| US-20110130587-A1 | PROCESS FOR PREPARING R-BETA-AMINO PHENYLBUTYRIC ACID DERIVATIVES | ALAD, DAO, DDO | EPHX1 3050/4885CPA1 2059/4885CPB1 1032/4885 |
| US-20200157149-A1 | Cell Permeable Cyclic Peptide Scaffolds | VIP, IAPP, HM13 | EPHX1 4192/4885CPA1 354/4885CPB1 553/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.